Dietrich A. Stephan

Insider Reports History

Entity
Individual
Location
213 Smithfield St, Pittsburgh, PA
Signature
/s/ Todd P. Branning
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dietrich A. Stephan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NeuBase Therapeutics, Inc. Founder and CEO, Director, 10%+ Owner Common Stock 93.2K $179K $1.92 Aug 2, 2023 Direct
NeuBase Therapeutics, Inc. Founder and CEO, Director, 10%+ Owner Common Stock 63.7K $122K $1.92 Aug 2, 2023 Indirect
NeuBase Therapeutics, Inc. Founder and CEO, Director, 10%+ Owner Stock option (right to buy) 0 Aug 2, 2023 Direct

Insider Reports Filed by Dietrich A. Stephan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NBSE NeuBase Therapeutics, Inc. Aug 2, 2023 2 $2.05K 4 Aug 4, 2023 Founder and CEO, Director, 10%+ Owner
NBSE NeuBase Therapeutics, Inc. Mar 16, 2023 1 $0 4 Mar 17, 2023 CEO and Director, Director, 10%+ Owner
NBSE NeuBase Therapeutics, Inc. Feb 13, 2023 2 $0 4 Feb 15, 2023 President and CEO, Director, 10%+ Owner
NBSE NeuBase Therapeutics, Inc. Sep 28, 2022 2 $0 4 Sep 30, 2022 CEO, Director, 10%+ Owner
NBSE NeuBase Therapeutics, Inc. Jan 24, 2022 1 $0 4 Jan 25, 2022 President and CEO, Director, 10%+ Owner
NBSE NeuBase Therapeutics, Inc. Dec 31, 2021 2 $0 4 Jan 5, 2022 President and CEO, Director, 10%+ Owner